Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US7655688B2 · kind B2 · utility
3Cited by
118References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 19, 2005 |
| Grant date | Feb 2, 2010 |
| Priority date | — |
| Expiry date | Mar 19, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Fused cyclic compounds, methods of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.